Mark Marmur

Bio:

Mark Marmur is Vice President of Global Corporate Communications & Investor Relations at Amarin Corporation, a biopharmaceutical firm specializing in cardiovascular health. Mark has over two decades of expertise in shaping corporate narratives, driving global communications strategy, investor relations, media engagement, and executive messaging for healthcare and biotech companies.

Prior to Amarin, Mark held significant in-house public relations and communication positions across the pharma sector, including:

• VP of Corporate Communications at Asklepios BioPharmaceutical
• VP of Corporate Brand Communications at Allergan Aesthetics (under AbbVie)
• Various senior public relations and executive communications roles at Watson/Actavis/Allergan, including serving as Allergan’s lead spokesperson

Earlier in his career, he spent several years with Makovsky + Company, rising from Account Supervisor to Group Vice President. Mark began his career in healthcare public relations at MCS Health in New Jersey. 

Mark earned both his B.A. and M.A. in Corporate Public Relations from Rowan University. He is based in Doylestown, PA with his wife Tara and two sons, William and Evan.